Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...
Q3 2025 Earnings Call Transcript October 29, 2025 MiMedx Group, Inc. beats earnings expectations. Reported EPS is $0.15, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback